Journal of Pediatric Urology
Volume 4, Issue 1 , Pages 20-26 , February 2008

Health-related quality of life in children with vesicoureteral reflux – Impact of successful endoscopic therapy

  • C. Schwentner

      Affiliations

    • Department of Paediatric Urology, Medical University, Anichstr. 35, 6020 Innsbruck, Austria
    • C.S. and I.S. contributed equally.
    • ,
  • J. Oswald

      Affiliations

    • Department of Paediatric Urology, Medical University, Anichstr. 35, 6020 Innsbruck, Austria
    • ,
  • A. Lunacek

      Affiliations

    • Department of Paediatric Urology, Medical University, Anichstr. 35, 6020 Innsbruck, Austria
    • ,
  • B. Schlenck

      Affiliations

    • Department of Paediatric Urology, Medical University, Anichstr. 35, 6020 Innsbruck, Austria
    • ,
  • A.E. Pelzer

      Affiliations

    • Department of Paediatric Urology, Medical University, Anichstr. 35, 6020 Innsbruck, Austria
    • ,
  • I. Schwentner

      Affiliations

    • Department of Medical Psychology and Psychotherapy, Medical University, Anichstr. 35, 6020 Innsbruck, Austria
    • C.S. and I.S. contributed equally.
    • ,
  • S. Hofer

      Affiliations

    • Department of Medical Psychology and Psychotherapy, Medical University, Anichstr. 35, 6020 Innsbruck, Austria
    • ,
  • G. Bartsch

      Affiliations

    • Department of Paediatric Urology, Medical University, Anichstr. 35, 6020 Innsbruck, Austria
    • ,
  • C. Radmayr

      Affiliations

    • Department of Paediatric Urology, Medical University, Anichstr. 35, 6020 Innsbruck, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 512 504 24811; fax: +43 512 504 28365.

Received 22 May 2007 ,Accepted 3 August 2007.

References 

  1. Elder JS, Peters CA, Arant BS, Ewalt DH, Hawtrey CE, Hurwitz RS, et al. Pediatric vesicoureteral reflux guideline panel summary report on the management of primary vesicoureteral reflux in children. J Urol. 1997;157:1846–1851
  2. Austin JC, Cooper CS. Vesicoureteral reflux: surgical approaches. Urol Clin North Am. 2004;31:543–557
  3. Matouschek E. New concept for the treatment of vesicoureteral reflux. Endoscopic application of Teflon. Arch Esp Urol. 1981;34:385–388
  4. O'Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed). 1984;289:5–7
  5. Stenberg A, Läckgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol. 1995;154:800–803
  6. Elder JS, Diaz M, Caldamone AA, Cendron M, Greenfield S, Hurwitz R, et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol. 2006;175:716–722
  7. Kirsch AJ, Perez-Brayfield MR, Scherz HC. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the children's hospitals of Atlanta experience. J Urol. 2003;170:211–215
  8. Caione P, Capozza N. Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: a randomized comparison with antibiotic prophylaxis. J Pediatr. 2002;140:230–234
  9. Puri P, Chertin B, Velayudham M, Dass L, Colhoun E. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results. J Urol. 2003;170:1541–1544
  10. Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC. The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol. 2004;171:2413–2416
  11. Capozza N, Lais A, Matarazzo E, Nappo S, Patricolo M, Caione P, et al. Treatment of vesico-ureteric reflux: a new algorithm based on parental preference. BJU Int. 2003;92:285–288
  12. Cella DF. Measuring quality of life in palliative care. Semin Oncol. 1995;22:73–81
  13. Aaronson NK. Quality of life: what is it? how should it be measured?. Oncology (Williston Park). 1988;2:69–7664 [review]
  14. Pal DK. Quality of life assessment in children: a review of conceptual and methodological issues in multidimensional health status measures. J Epidemiol Community Health. 1996;50:391–396
  15. Varni JW, Burwinkle TM, Lane MM. Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application. Health Qual Life Outcomes. 2005;3:34
  16. Yerkes EB, Cain MP, King S, Brei T, Kaefer M, Casale AJ, et al. The Malone antegrade continence enema procedure: quality of life and family perspective. J Urol. 2003;169:320–323
  17. Kubba H, Swan IR, Gatehouse S. The Glasgow children's benefit inventory: a new instrument for assessing health related benefit after an intervention. Ann Otol Rhinol Laryngol. 2004;113:980–986
  18. Schwentner I, Schwentner C, Schmutzhard J, Radmayr C, Grabherr G, Sprinzl G, et al. Validation of the German Glasgow children's benefit inventory. J Eval Clin Pract, 13, in press.
  19. Fischer D, Stewart AL, Bloch DA, Lorig K, Laurent D, Holman H, et al. Capturing the patient's view of change as a clinical outcome measure. JAMA. 1999;282:1157
  20. Lackgren G, Wahlin N, Skoldenberg E, Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol. 2001;166:1887–1892
  21. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. 2006;117:626–632
  22. Reddy PP, Evans MT, Hughes PA, Dangman B, Cooper J, Lepow ML, et al. Antimicrobial prophylaxis in children with vesico-ureteral reflux: a randomised prospective study of continuous therapy vs. intermittent therapy vs. surveillance. Pediatrics. 1997;100[Suppl]:555
  23. Faust WC, Pohl HG. Role of prophylaxis in vesicoureteral reflux. Curr Opin Urol. 2007;17:252–256
  24. Benoit RM, Peele PB, Docimo SG. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management. J Urol. 2006;176:1588–1592
  25. Ogan K, Pohl HG, Carlson D, Belman AB, Rushton HG. Parental preferences in the management of vesicoureteral reflux. J Urol. 2001;166:240–243
  26. Kobelt G, Canning DA, Hensle TW, Lackgren G. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol. 2003;169:1480–1484
  27. Stashinko EE, Goldberger J. Test or trauma? The voiding cystourethrogram experience of young children. Issues Compr Pediatr Nurs. 1998;21:85–96
  28. Lackgren G, Skoldenberg E, Stenberg A. Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. J Urol. 2007;177:1124–1128
  29. Diamond DA, Caldamone AA, Bauer SB, Retik AB. Mechanisms of failure of endoscopic treatment of vesicoureteral reflux based on endoscopic anatomy. J Urol. 2003;170:1556–1558

PII: S1477-5131(07)00385-3

doi: 10.1016/j.jpurol.2007.08.002

Journal of Pediatric Urology
Volume 4, Issue 1 , Pages 20-26 , February 2008

Article Tools

* Image Usage & Resolution